MARLAINA BROWN: Open Payments
NPI 1659023059 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 17 payments from 4 companies in 2025. Trend: 2023 $225 · 2024 $443 · 2025 $490
Food & beverage: $300Education: $190
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $338 |
| Sumitomo Pharma America, Inc. | 6 | $111 |
| MILLICENT US INC | 2 | $36 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $5 |
Products named: Veozah, GEMTESA, MYFEMBREE, INTRAROSA, FEMRING.
Industry payments across NY — which companies pay providers there.
